SEC Filing Details
Document Details
Form
Filing Date
May 28, 2021
Document Date
May 24, 2021
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Cerevel Therapeutics
Issuer
CEREVEL THERAPEUTICS HOLDINGS, INC.
Filer
AKAMINE SCOTT
Cerevel is now part of AbbVie
Together we will deliver science that takes us closer to meaningful change for people with neurological and psychiatric disorders.